SEARCH RESULTS FOR: "Tag: COLL"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(1)
2017(2)
CATEGORIES
Analyst Update(4)
Buzz Stocks(1)
Stocks On the Move(1)

5/3/2019 11:32 AM
H.C. Wainwright just initiated coverage on the drugmaker Collegium Pharmaceutical, Inc (NASDAQ:COLL) with a "buy" rating and a $23 price target -- a roughly 60% upside to the stock's current perch at...
4/12/2019 10:13 AM
Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) are making positive moves this morning, just after landing a "buy" rating and $29 price target out of Janney Montgomery. This type of bull note is ...
6/12/2018 1:32 PM
The shares of healthcare concerns Collegium Pharmaceutical Inc (NASDAQ:COLL) and Stemline Therapeutics Inc (NASDAQ:STML) are higher today, thanks to some upbeat analyst attention. Specifically, Ca...
12/5/2017 2:33 PM
U.S. stocks are slightly higher this afternoon. Among the names making big moves are homebuilder Toll Brothers Inc (NYSE:TOL), biotech Revance Therapeutics Inc (NASDAQ:RVNC), and pharma stock Colleg...
12/5/2017 9:24 AM
Shares of Depomed Inc (NASDAQ:DEPO) are almost 12% higher in electronic trading, after the biotech said it is licensing the sales rights to its opioid pain drugs, Nucynta IR and Nucynta ER, to Colle...
PEOPLE ALSO SEARCH FOR
 
Special Offers from Schaeffer's Trading Partners